optio semaglutide/niacinamide Help with dosing, please. : r/SemaglutideFreeSpeech Good Molecules - 2.5 oz
Description
While the evidence regarding GLP-1 receptor expression in testosterone-producing tissues is limited and mixed in humans, the metabolic changes induced by semaglutideparticularly significant weight loss and improved insulin sensitivitycan indirectly affect hormone balance
This is the dose that produced 24.2% average weight loss at 48 weeks in Phase 2 and up to 28.7% in the Phase 3 TRIUMPH-4 trial at 68 weeks
Related reading: Can Microdosing GLP 1 Enhance Fat Loss During the Fitness Definition Phase?, and how it is evaluated and treated at Perfect B in Doral
In two phase 3 clinical trials, retatrutide, a novel glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon triple-hormone receptor agonist, demonstrated significant weight loss and clinically meaningful improvements in health outcomes in people living with obesity and type 2 diabetes
